Clinical Trials Browser

Unknown × OTHER_GOV × pyrotinib × Clear all

NCT03691051 2023-09-25

A Study of Pyrotinib Plus Capecitabine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer

Phase 2 Unknown

HER2 Positive Metastatic Breast Cancer

NCT04293276 2023-05-06

DAP-Her-01

Phase 2 Unknown

Breast Neoplasms

NCT03947242 2019-05-15

Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Vinorelbine in Trastuzumab-refractory HER2-Positive Breast Cancer.

Phase NA Unknown

HER2 Positive Breast Cancer